The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...

Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene therapy to ...

They come in two types: NTC, or Negative Temperature Coefficient thermistors, where as the temperature increases their resistance decreases, and PTC, or Positive Temperature Coefficient ...

PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...

Vishay has introduced an automotive-rated series of positive temperature coefficient (PTC) in-rush current thermistors.

Sami Corwin has given his Buy rating due to a combination of factors that favor PTC Therapeutics’ market position. The recent FDA approval of Kebilidi, a groundbreaking gene therapy for AADC ...

PTC Therapeutics (NASDAQ:PTCT) has received FDA approval for its gene replacement therapy Kebilidi for the treatment of ...

Manufactures PTC and NTC thermistors (THERMally sensitive resistors) and thermistor temperature probe Pressure sensors. Thermistors for overcurrent overload protection, temperature sensing measurement ...

Industrial software maker PTC forecast first-quarter revenue below estimates on Wednesday, signaling continued weakness in ...

PTC Therapeutics (PTCT) announced that the FDA accelerated approval of its gene therapy for the treatment of AADC deficiency, the first-ever ...

Fiscal '25 Constant Currency ARR Growth Guidance: 9% to 10%. PTC Inc (NASDAQ:PTC) reported a solid 25% year-over-year growth in free cash flow for fiscal 2024. The company achieved a 12% year-over ...

PTC Inc. (PTC) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.20 per share a year ago. These figures are ...